Merck Serono has redeployed a fifth of axed Swiss staff

October 2, 2012
Manufacturing and Production Geneva, Merck Serono

Merck Serono says it has redeployed 260 of 1,250 staff affected by the closure and downsizing of sites in Switzerland …

Lonza image

Lonza wins contract to make gene therapy for heart failure

October 2, 2012
Manufacturing and Production Celladon, Lonza, Mydicar

Lonza has been awarded a contract by US firm Celladon for the manufacture of Mydicar, a gene therapy-based drug candidate …

Sigma-Aldrich invest in Scottish site

October 2, 2012
Manufacturing and Production Bioreliance, Irvine, Scotland, Sigma-Aldrich

Sigma-Aldrich has announced an expansion of its operations in Scotland with the construction of a powder manufacturing facility at its …

Pharma manufacturing news in brief

October 2, 2012
Manufacturing and Production BIA Seperations, Hovione, Lonza, Merck Millipore

Hovione invests in particle design, Lonza signs deal for ADC production plus bioprocess news from BIA Separations and Merck Millipore.

J&J cancer drugs get EU approval

October 2, 2012
Sales and Marketing Cancer, Dacogen, EU, J&J, JJ, Velcade

Two of Johnson & Johnson’s key cancer drugs have been shown the green light from the European Commission. Janssen-Cilag International’s …

Cmed Clinical Services Strengthens Management Team

October 1, 2012
Research and Development

HORSHAM, UK — September 13, 2012 – Cmed Clinical Services has today announced three new appointments to its management team …

yervoy image

BMS highlights Yervoy survival data

October 1, 2012
Research and Development, Sales and Marketing BMS, Roche, Yervoy, Zelboraf

Bristol-Myers Squibb’s melanoma drug Yervoy helps patients survive for longer than if they are receiving standard chemotherapy alone, according to …

paul_chew_medlo

Sanofi appoints Paul Chew as chief medical officer

October 1, 2012
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Paul Chew, Sanofi

Sanofi has appointed Dr Paul Chew as chief medical officer and head of global medical affairs. Taking up his post …

FDA approves Bayer’s Stivarga

October 1, 2012
Research and Development, Sales and Marketing Bayer, FDA, KRAS, Roche, Stivarga, avastin

The FDA has approved Bayer HealthCare’s oncology pill Stivarga to treat patients with metastatic colorectal cancer (mCRC) whose disease has …

Merck image

Merck gives back vernakalant rights

September 28, 2012
Sales and Marketing AF, Cardiome, Merck, vernakalant

Merck has dealt a further blow to Cardiome Pharma Corp by handing back all marketing and development rights for the …

International guide to social media launched by TranslateMedia

September 28, 2012
Medical Communications

TranslateMedia, the international translation agency, has created an international guide to social media, to help agencies navigate social media use …

engelbert_tjeenk_willink_pv

Boehringer’s Engelbert Tjeenk Willink leaves firm

September 28, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Boehringer Ingelheim, Engelbert Tjeenk Willink

Boehringer Board member Engelbert Tjeenk Willink, responsible for Marketing and Sales of Prescription Medicines, has decided to leave at the …

Victrelis image

Two hepatitis C drugs win Prix Galien

September 28, 2012
Medical Communications, Sales and Marketing Incivo, Janssen, MSD, Victrelis, prix galien

Two new hepatitis C drugs have been given the 2012 UK Prix Galien innovative product award as joint winners in …

Vertex abandons hep C drug

September 27, 2012
Research and Development, Sales and Marketing Alios BioPharma, Vertex, hep C

Vertex Pharmaceutical’s pipeline has been dealt a blow with the abandonment of an investigational hepatitis C compound. The US firm, …

NHS image

CCG warning for doctors from BMA

September 27, 2012
Sales and Marketing BMA, CCG, NHS, doctors

GPs have been urged to scrutinise the small print of the new clinical commissioning group (CCG) constitutions before they sign …

andrew_witty_gsk

GlaxoSmithKline announces Board changes

September 27, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, Witty

GlaxoSmithKline has announced several changes to its Board and Committee structure. The GSK Board of directors with effect from 1 …

Roche image

Roche unveils New York research base

September 26, 2012
Research and Development New York, Nutley, Roche, translational research

Roche is to locate a new translational clinical research centre in central New York, as part of a shift towards …

Trajenta added to insulin recommended in Europe

September 26, 2012
Sales and Marketing Boehringer Ingelheim, Trajenta, diabetes

The CHMP has recommended that Boehringer Ingelheim and Eli Liily and Co’s diabetes brand Trajenta should be approved as add-on …

sanofi_hq_reception_close

Sanofi to cut 900 jobs in France

September 26, 2012
Research and Development Jobs, Sanofi, pharma job cuts, restructuring

Sanofi is to cut 900 jobs in its French operations by 2015 – fewer than expected after widespread speculation this …

Novo Nordisk image

Novo Nordisk to expand Beijing R&D centre

September 25, 2012
Research and Development, Sales and Marketing Beijing, China, Novo Nordisk, R&D

Novo Nordisk is investing $100 million into enlarging its R&D facilities in Beijing into a state-of-the-art centre. Located in the …

The Gateway to Local Adoption Series

Latest content